Wandel J C, Ivkovic C, Morocco Y
Appl Nurs Res. 1990 Aug;3(3):122-4. doi: 10.1016/s0897-1897(05)80129-6.
We found a prevalence rate of elevated blood pressure readings in our sample of 86 nonacute EU patients without history of hypertension that was similar to that reported by the author of a previous study (Franklin, 1987) done in the same setting and continue to advocate the use of the EU as a site for hypertension screening. However, the noted prevalence rate in this and other samples may not accurately reflect the true prevalence of elevated readings or true hypertension in this population. Most of the elevated readings in our study were in the borderline or mild categories, and many of the readings on subsequent visits were normal. Although patients with a newly elevated blood pressure during an EU visit should certainly be advised to have their blood pressure followed, further controlled study is needed to determine the true prevalence of previously undetected hypertension in nonacute EU patients.
我们在86例无高血压病史的非急性欧盟患者样本中发现血压读数升高的患病率，与之前在相同环境下进行的一项研究（Franklin，1987年）的作者报告的患病率相似，并继续提倡将欧盟作为高血压筛查地点。然而，该样本及其他样本中记录的患病率可能无法准确反映该人群中血压读数升高或真正高血压的真实患病率。我们研究中的大多数血压升高读数处于临界或轻度类别，且后续就诊时的许多读数均正常。虽然在欧盟就诊期间血压新升高的患者当然应被建议监测其血压，但需要进一步的对照研究来确定非急性欧盟患者中先前未被检测到的高血压的真实患病率。
